📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Brabant Pharma

1.1 - Company Overview

Brabant Pharma Logo

Brabant Pharma

Headquarter: Vietnam
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a late-stage oral treatment, Brabafen, under development for children with Dravet Syndrome (severe myoclonic epilepsy of infancy), a rare childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Brabant Pharma

HemoShear Logo

HemoShear

HQ: United States Website
  • Description: Provider of the REVEAL-Tx platform, a drug discovery system combining biological and computational models to accelerate development of treatments for rare disorders. Offerings include HST5040, a clinical candidate for Propionic Acidemia and Methylmalonic Acidemia, and a human tissue-based model of rare liver disease developed in collaboration with Takeda.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HemoShear company profile →
Amryt Pharma Logo

Amryt Pharma

HQ: Ireland Website
  • Description: Provider of specialty pharmaceuticals for rare and orphan diseases: Myalept/Myalepta (metreleptin) for leptin deficiency complications in generalized or partial lipodystrophy; Mycapssa (octreotide capsules) for long-term maintenance therapy in acromegaly; Juxtapid/Lojuxta (lomitapide) for adults with HoFH; Filsuvez (Oleogel-S10) for partial-thickness wounds in junctional and dystrophic EB; and AP103, a pre-clinical gene therapy for DEB.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amryt Pharma company profile →
Minoryx Therapeutics Logo

Minoryx Therapeutics

HQ: Spain Website
  • Description: Provider of pharmacological chaperone small-molecule drugs for genetic, neurometabolic, and rare pediatric diseases. Develops leriglitazone, a selective PPAR gamma agonist for X-linked adrenoleukodystrophy and other CNS diseases, supported by phase 2/3 results. Programs include ADVANCE (adult X-ALD), NEXUS (pediatric cALD), CALYX (adult progressive cALD), and a Friedreich's ataxia proof-of-concept.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Minoryx Therapeutics company profile →
Synageva BioPharma Logo

Synageva BioPharma

HQ: United States Website
  • Description: Provider of novel, next generation and follow on protein therapeutics developed and commercialized using the proprietary Synageva Expression Platform (SEPTM).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synageva BioPharma company profile →
Engage Therapeutics Logo

Engage Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical R&D focused on epilepsy, developing Staccato alprazolam, a small, easy-to-use hand-held drug-device combination that leverages an FDA-approved delivery system with FDA-approved alprazolam.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Engage Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Brabant Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Brabant Pharma

2.2 - Growth funds investing in similar companies to Brabant Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Brabant Pharma

4.2 - Public trading comparable groups for Brabant Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Brabant Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Brabant Pharma

What does Brabant Pharma do?

Brabant Pharma is a provider of a late-stage oral treatment, Brabafen, under development for children with Dravet Syndrome (severe myoclonic epilepsy of infancy), a rare childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment.

Who are Brabant Pharma's competitors?

Brabant Pharma's competitors and similar companies include HemoShear, Amryt Pharma, Minoryx Therapeutics, Synageva BioPharma, and Engage Therapeutics.

Where is Brabant Pharma headquartered?

Brabant Pharma is headquartered in Vietnam.

How many employees does Brabant Pharma have?

Brabant Pharma has 1,000 employees 🔒.

When was Brabant Pharma founded?

Brabant Pharma was founded in 2010 🔒.

What sector and industry vertical is Brabant Pharma in?

Brabant Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Brabant Pharma

Who are the top strategic acquirers in Brabant Pharma's sector and industry

Top strategic M&A buyers and acquirers in Brabant Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Brabant Pharma?

Top strategic M&A buyers groups and sectors for Brabant Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Brabant Pharma's sector and industry vertical

Which are the top PE firms investing in Brabant Pharma's sector and industry vertical?

Top PE firms investing in Brabant Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Brabant Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Brabant Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Brabant Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Brabant Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Brabant Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Brabant Pharma?

The key public trading comparables and valuation benchmarks for Brabant Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Brabant Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Brabant Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Brabant Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Brabant Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Brabant Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Brabant Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Brabant Pharma